Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease

References

• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• Gimeno-Santos E, Frei A, Steurer-Stey C, et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax. 2014;69(8):731–739. doi:10.1136/thoraxjnl-2013-204763
   PubMed Web of Science ®Google Scholar
• Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. doi:10.1378/chest.10-2521
   PubMed Web of Science ®Google Scholar
• Buhl R, Maltais F, Abrahams R, et al. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4). Eur Respir J. 2015;45(4):969–979. doi:10.1183/09031936.00136014
   PubMed Web of Science ®Google Scholar
• Blair HA. Tiotropium/olodaterol: a review in COPD. Drugs. 2019;79(9):997–1008. doi:10.1007/s40265-019-01133-w
   PubMed Web of Science ®Google Scholar
• Calverley PMA, Anzueto AR, Carter K, et al. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. Lancet Respir Med. 2018;6(5):337–344. doi:10.1016/S2213-2600(18)30102-4
   PubMed Web of Science ®Google Scholar
• Nici L, Mammen MJ, Charbek E, et al. Pharmacologic management of chronic obstructive pulmonary disease. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(9):e56–e69. doi:10.1164/rccm.202003-0625ST
   PubMed Web of Science ®Google Scholar
• Rabe KF, Chalmers JD, Miravitlles M, et al. Tiotropium/olodaterol delays clinically important deterioration compared with tiotropium monotherapy in patients with early COPD: a post hoc analysis of the TONADO((R)) trials. Adv Ther. 2021;38(1):579–593. doi:10.1007/s12325-020-01528-2
   PubMed Web of Science ®Google Scholar
• Watz H, Pitta F, Rochester CL, et al. An official European respiratory society statement on physical activity in COPD. Eur Respir J. 2014;44(6):1521–1537. doi:10.1183/09031936.00046814
   PubMed Web of Science ®Google Scholar
• Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc. 1983;31(12):721–727. doi:10.1111/j.1532-5415.1983.tb03391.x
   PubMed Web of Science ®Google Scholar
• Wan ES, Kantorowski A, Homsy D, et al. Self-reported task-oriented physical activity: a comparison with objective daily step count in COPD. Respir Med. 2018;140:63–70. doi:10.1016/j.rmed.2018.05.012
   PubMed Web of Science ®Google Scholar
• Sugino A, Minakata Y, Kanda M, et al. Validation of a compact motion sensor for the measurement of physical activity in patients with chronic obstructive pulmonary disease. Respiration. 2012;83(4):300–307. doi:10.1159/000330046
   PubMed Web of Science ®Google Scholar
• Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575–1581. doi:10.1249/MSS.0b013e31821ece12
   PubMed Web of Science ®Google Scholar
• Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(9):972–977. doi:10.1164/rccm.200407-855OC
   PubMed Web of Science ®Google Scholar
• Gouzi F, Prefaut C, Abdellaoui A, et al. Evidence of an early physical activity reduction in chronic obstructive pulmonary disease patients. Arch Phys Med Rehabil. 2011;92(10):1611–1617 e1612. doi:10.1016/j.apmr.2011.05.012
   PubMed Web of Science ®Google Scholar
• Ichinose M, Minakata Y, Motegi T, et al. A non-interventional, Cross-Sectional Study to evaluate factors relating to daily step counts and physical activity in Japanese patients with chronic obstructive pulmonary disease: STEP COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:3385–3396. doi:10.2147/COPD.S277782
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Tremblay MS, Aubert S, Barnes JD, et al. Sedentary Behavior Research Network (SBRN) terminology consensus project process and outcome. Int J Behav Nutr Phys Act. 2017;14(1):75. doi:10.1186/s12966-017-0525-8
   PubMed Web of Science ®Google Scholar
• Takahashi K, Uchida M, Kato G, et al. First-line treatment with tiotropium/olodaterol improves physical activity in patients with treatment-naive chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:2115–2126. doi:10.2147/COPD.S268905
   PubMed Web of Science ®Google Scholar
• Minakata Y, Sasaki S. Data reproducibility and effectiveness of bronchodilators for improving physical activity in COPD patients. J Clin Med. 2020;9(11):3497. doi:10.3390/jcm9113497
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J. 2009;33(2):262–272. doi:10.1183/09031936.00024608
   PubMed Web of Science ®Google Scholar
• Troosters T, Sciurba F, Battaglia S, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med. 2010;104(7):1005–1011. doi:10.1016/j.rmed.2010.01.012
   PubMed Web of Science ®Google Scholar
• Wahid A, Manek N, Nichols M, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc. 2016;5(9). doi:10.1161/JAHA.115.002495
   PubMed Web of Science ®Google Scholar
• Biswas A, Oh PI, Faulkner GE, et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med. 2015;162(2):123–132. doi:10.7326/M14-1651
   PubMed Web of Science ®Google Scholar
• Park J, Ishikawa-Takata K, Tanaka S, Mekata Y, Tabata I. Effects of walking speed and step frequency on estimation of physical activity using accelerometers. J Physiol Anthropol. 2011;30(3):119–127. doi:10.2114/jpa2.30.119
   PubMed Web of Science ®Google Scholar
• Furlanetto KC, Donaria L, Schneider LP, et al. Sedentary behavior is an independent predictor of mortality in subjects with COPD. Respir Care. 2017;62(5):579–587. doi:10.4187/respcare.05306
   PubMed Web of Science ®Google Scholar
• Ding D, Mutrie N, Bauman A, Pratt M, Hallal PRC, Powell KE. Physical activity guidelines 2020: comprehensive and inclusive recommendations to activate populations. Lancet. 2020;396(10265):1780–1782. doi:10.1016/S0140-6736(20)32229-7
   PubMed Web of Science ®Google Scholar
• Saunders TJ, McIsaac T, Douillette K, et al. Sedentary behaviour and health in adults: an overview of systematic reviews. Appl Physiol Nutr Metab. 2020;45(10 (Suppl. 2)):S197–S217. doi:10.1139/apnm-2020-0272
   PubMed Web of Science ®Google Scholar
• Piercy KL, Troiano RP, Ballard RM, et al. The physical activity guidelines for Americans. JAMA. 2018;320(19):2020–2028. doi:10.1001/jama.2018.14854
   PubMed Web of Science ®Google Scholar
• Troosters T, Maltais F, Leidy N, et al. Effect of bronchodilation, exercise training, and behavior modification on symptoms and physical activity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(8):1021–1032. doi:10.1164/rccm.201706-1288OC
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis. 1993;148(5):1351–1357. doi:10.1164/ajrccm/148.5.1351
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(5):770–777. doi:10.1164/ajrccm.164.5.2012122
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Elbehairy AF, Webb KA, Neder JA; Canadian Respiratory Research N. The link between reduced inspiratory capacity and exercise intolerance in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2017;14(Supplement_1):S30–S39. doi:10.1513/AnnalsATS.201610-834FR
   PubMedGoogle Scholar
• Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med. 2009;180(6):506–512. doi:10.1164/rccm.200812-1873OC
   PubMed Web of Science ®Google Scholar
• Ichinose M, Minakata Y, Motegi T, et al. Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity. Int J Chron Obstruct Pulmon Dis. 2018;13:1407–1419. doi:10.2147/COPD.S166023
   PubMed Web of Science ®Google Scholar
• Minakata Y, Motegi T, Ueki J, et al. Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO((R)) study. Int J Chron Obstruct Pulmon Dis. 2019;14:1789–1801. doi:10.2147/COPD.S208081
   PubMed Web of Science ®Google Scholar
• Dogra S, Good J, Gardiner PA, et al. Effects of replacing sitting time with physical activity on lung function: an analysis of the Canadian Longitudinal Study on aging. Health Rep. 2019;30(3):12–23. doi:10.25318/82-003-x201900300002-eng
   PubMed Web of Science ®Google Scholar
• Lewis LK, Hunt T, Williams MT, English C, Olds TS. Sedentary behavior in people with and without a chronic health condition: how much, what and when? AIMS Public Health. 2016;3(3):503–519. doi:10.3934/publichealth.2016.3.503
   PubMed Web of Science ®Google Scholar